Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Fenwal, Inc.. The primary component is Anhydrous Citric Acid; Dextrose Monohydrate; Sodium Phosphate, Monobasic, Monohydrate; Trisodium Citrate Dihydrate.
Product ID | 0942-9201_1ee1e424-2028-4b58-b554-883d2e359c28 |
NDC | 0942-9201 |
Product Type | Human Prescription Drug |
Proprietary Name | Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic |
Generic Name | Anticoagulant Citrate Phosphate Dextrose (cpd) Solution |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2007-03-01 |
Marketing Category | NDA / NDA |
Application Number | BN170401 |
Labeler Name | Fenwal, Inc. |
Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
Active Ingredient Strength | 105 mg/35mL; mg/35mL; mg/35mL; mg/35mL |
Pharm Classes | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |